| RS45481704 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45481995 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS45482398 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45482795 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45483301 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45483391 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS45483392 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis 2, Lymphangiomyomatosis |
| RS45483395 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Usher syndrome type 1F |
| RS45483396 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome |
| RS45484298 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45484791 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS45484794 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45484892 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45484992 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45485092 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45485395 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45485591 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Seizure |
| RS45486193 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45486196 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45486293 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS45486496 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS45486591 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45486906 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45487291 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45487691 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45487695 |
MOCS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, MOCS1-related disorder |
| RS45487699 |
LDB3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1C, Familial hypertrophic cardiomyopathy 24 |
| RS45488101 |
SFTPB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pulmonary alveolar proteinosis, Hereditary pulmonary alveolar proteinosis |
| RS45488199 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS45488500 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Cortical tubers |
| RS45488595 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS45488893 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45489099 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome 3 |
| RS45489199 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brugada syndrome 1 |
| RS45489591 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS45489791 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45490993 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45491005 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS45491095 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45491398 |
GJC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS45491698 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45492397 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45492700 |
PLCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS45493191 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS45493394 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS45493995 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS45494092 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45494392 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45495192 |
TCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2G, Hypertrophic cardiomyopathy 25 |
| RS45495500 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS45495503 |
EPB42
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 5, Hereditary spherocytosis type 5 |
| RS45495796 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45496291 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45496292 |
COQ6
|
Health Risk |
Conflicting classifications of pathogenicity |
COQ6-related disorder, Lung cancer |
| RS45496402 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS45496496 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, MYH7-related skeletal myopathy |
| RS45496499 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45496799 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS45497997 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45498496 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis syndrome |
| RS45498797 |
CSRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 12, Cardiomyopathy |
| RS45498892 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45499704 |
TSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperthyroidism due to mutations in TSH receptor, Hypothyroidism due to TSH receptor mutations |
| RS45500091 |
BRD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS45500891 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Usher syndrome type 2A |
| RS45501091 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Everolimus response |
| RS45501492 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45501500 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Hypertrophic cardiomyopathy 2 |
| RS45501594 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Alstrom syndrome |
| RS45501596 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45501894 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS45502196 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45502703 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS45502896 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 10, Meckel-Gruber syndrome |
| RS45503297 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease |
| RS45503898 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant tumor of esophagus, Malignant tumor of esophagus |
| RS45503995 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45504193 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 5 with or without anosmia, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS45504597 |
SFTPB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pulmonary alveolar proteinosis, Hereditary pulmonary alveolar proteinosis |
| RS45505405 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lymphangiomyomatosis |
| RS45505500 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45505791 |
SFTPB
|
Health Risk |
Conflicting classifications of pathogenicity |
Surfactant metabolism dysfunction, pulmonary |
| RS45505995 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis syndrome |
| RS45506197 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45506294 |
TCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2G, Hypertrophic cardiomyopathy 25 |
| RS45506396 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45506401 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45507199 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45507693 |
IL1RN
|
Health Risk |
Conflicting classifications of pathogenicity |
Sterile multifocal osteomyelitis with periostitis and pustulosis, Autoinflammatory syndrome |
| RS45508997 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45509094 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45509392 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45509500 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45509697 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45509791 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45510294 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS45510998 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45511697 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, ADA2-related disorder |
| RS45512093 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS45512692 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |